Medison Ventures
Overview
Medison Ventures is the corporate venture arm of Medison Pharma, a global pharmaceutical company focused on providing access to highly innovative therapies to patients in international markets. Leveraging over two decades of clinical and commercial expertise, Medison Ventures identifies and executes opportunities that add value to both Medison and its partners. The firm immerses itself in the healthcare ecosystem by engaging with academia, medical centers, patients, global pharma partners, and key opinion leaders. This comprehensive approach enables Medison Ventures to evaluate breakthrough technologies across various development stages and assess industry adoption readiness. The firm's investment strategy encompasses a wide range of stages, from seed to pre-IPO, and spans multiple geographical regions, including Israel, the United States, Europe, and parts of Asia and Africa. Medison Ventures focuses on sectors such as biotechnology, digital health, pharmaceuticals, medical devices, and healthcare IT. By acting as 'external R&D' for its global partners, the firm continuously researches and evaluates opportunities tailored to meet specific partner needs, driving pipeline growth and supporting long-term visions. Medison Ventures has made notable investments in companies such as Alpha Tau Medical, Orchard Therapeutics, and Allogene Therapeutics, focusing on sectors like biotechnology and drug discovery. Through its strategic alliances and investment vehicles, Medison Ventures seeks highly innovative products at advanced development stages for in-licensing and commercialization within Medison's covered territories. By acting as 'external R&D' for its global partners, the firm continuously researches and evaluates opportunities tailored to meet specific partner needs, driving pipeline growth and supporting long-term visions.
Investment Focus
- Innovative healthcare solutions
- Advanced development stages
- Potential for global commercialization
- Alignment with Medison's strategic interests
Portfolio Companies
Reach Medison Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Medison Ventures
What sectors does Medison Ventures invest in?
Medison Ventures invests in Digital Health, Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology and Oncology, and is based in Hamerkaz, Israel. Medison Ventures is listed as a vc in the ConnectSafely investor database.
What stage does Medison Ventures invest at?
Medison Ventures backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Medison Ventures invest in?
Medison Ventures invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
What companies has Medison Ventures invested in?
Medison Ventures's portfolio includes Allogene Therapeutics, Orchard Therapeutics and Alpha TAU Medical.
Last updated · Source: ConnectSafely investor database